Large-scale, multicenter study of cerebrospinal fluid tau protein phosphorylated at serine 199 for the antemortem diagnosis of Alzheimer's disease-Reference-Cited by-同舟云学术

Large-scale, multicenter study of cerebrospinal fluid tau protein phosphorylated at serine 199 for the antemortem diagnosis of Alzheimer's disease

Published:2001 Issue:2 Volume:50 Page:150-156
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Itoh Nobuo,Arai Hiroyuki,Urakami Katsuya,Ishiguro Koichi,Ohno Hideto,Hampel Harald,Buerger Katharina,Wiltfang Jens,Otto Markus,Kretzschmar Hans,Moeller Hans-Juergen,Imagawa Masaki,Kohno Hideki,Nakashima Kenji,Kuzuhara Shigeki,Sasaki Hidetada,Imahori Kazutomo

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Reference29 articles.

1. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

2. Diagnosis of Alzheimer's Disease

3. Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease” 11The names of the Working Group Members and the names of the Working Group Advisory Committee Members are listed in the Appendix A(section VI). 22The Reagan Institute Working Groups are planned and organized by Z. S. Khachaturian and T.S. Radebaugh; Fax: 301-879-2023; E-mail: zaven@idt.net.

4. Tau in cerebrospinal fluid: A potential diagnostic marker in Alzheimer's disease

Cited by 195 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neurofilaments and progranulin are related to atrophy in frontotemporal lobar degeneration – A transdiagnostic study cross‐validating atrophy and fluid biomarkers;Alzheimer's & Dementia;2024-06-12

2. Novel Biomarkers for Alzheimer’s Disease: Plasma Neurofilament Light and Cerebrospinal Fluid;International Journal of Alzheimer's Disease;2024-05-15

3. Investigating the Potential Impact of Air Pollution on Alzheimer’s Disease and the Utility of Multidimensional Imaging for Early Detection;ACS Omega;2024-02-15

4. Biomarkers for Alzheimer's Disease – An Overview;Macromolecular Symposia;2024-02

5. Prevalence and Clinical Implications of a β-Amyloid–Negative, Tau-Positive Cerebrospinal Fluid Biomarker Profile in Alzheimer Disease;JAMA Neurology;2023-09-01